U.S. :
+1-206-701-6702
UK :
+44-020-8133-4027
JAPAN :
+050-5539-1737
INDIA :
+91-848-285-0837
Increasing patient awareness and rising demand for high quality care have made it imperative for healthcare providers to develop targeted therapies through specific and sensitive diagnostic tests. Clinical diagnostic tests are used to diagnose a medical condition, provide information about the patient’s health, or monitor a course of disease and assess the patient’s response to treatments. Various techniques of clinical diagnostic testing include blood gas testing, clinical chemistry, immunoassay, coagulation testing, hematology, polymerase chain reaction (PCR), and staining method.
Typically, clinical diagnostic tests involve use of antibody-based techniques for recognizing proteins or disease markers. However, these immunoassays cannot identify all biomarkers in one test and are prone to false-positive and false-negative results. Therefore, there is growing demand for more accurate, efficient, and reliable technologies. This has led to development of alternative testing methods such as LC-MS and GC-MS. However, high initial capital investment and lack of skilled labor is deterring adoption of advance testing devices. Major instruments used in clinical diagnostics include immunoassay analyzer, HPLC system, chemical analyzer, mass spectrometer (MS), LC-MS, and GC-MS. The use of reagents has simplified the testing practice and workflow for personnel in diagnostic laboratories.
New Techniques in Use
Molecular diagnostics is driving growth of the personalized medicine market which involves co-development of drugs/devices and specialized diagnostic tests. The technique is also referred to as companion diagnostic and can be used for toxicity studies, dose selection, monitoring patient response, and patient stratification.
Rapid diagnostic tests are performed at the physician office laboratory (POL), hospitals, health centers and home care. Demand for these tests is increasing rapidly owing to faster and accurate results. Tests have been developed for HbA1c testing, drug abuse, pregnancy testing, micro albumin, creatinine, blood gases, RSV, etc.
Demand for In-vitro diagnostics (IVD) is increasing in emerging markets such as India, China, Brazil, and South Korea. In-vitro diagnostic techniques have transformed the diagnostics industry by eliminating the complex in-vivo testing methods. The IVD techniques include the advance PCR technique, assays and hematology testing, helps diagnose and monitor patient’s health condition using samples of blood, cells or tissues.
Immunoassay diagnostics is expected to be driven by technological advancements such as novel biomarkers, ultrasensitive detection system and assays.
Fragmented Market
The diagnostic landscape, especially in the emerging countries, is highly fragmented and marked by the strong presence of unorganized diagnostic labs. Global players are now building global networks by investing in foreign markets. Moreover, in terms of manufacturers, the market is fragmented in a similar manner with many small players dominating local markets. Owing to the increasing demand for home care, manufacturers and diagnostic laboratories need to work in collaboration to provide quality care at patient convenience.
Conclusion
Increasing healthcare costs is deterring patients from undergoing regular health tests that can be improved with a wider insurance coverage. Inadequate insurance coverage in emerging economies is restricting patients from undergoing expensive health tests, thus fueling the market growth. Moreover, centralization of testing laboratories is projected to drive demand for high volume instrumentation and automation equipment. Demand for IVD tests from Asia Pacific, Latin America and the Middle East markets is also increasing rapidly.
Newborn Screening Market – Insights Newborn screening describes various tests that are performed during first few hours or days of an infant’s life. These tests have the potential for preventing severe health problems, includ... Read more
Infectious Disease Diagnostics Market – Insights Infectious diseases are caused by pathogens such as bacteria, viruses, fungi or parasites. Infectious diseases spread from person to person either through di... Read more
Glycated Albumin Market - Insights Glycation is the process of bonding of a sugar molecule. For instance, glucose to a protein or a lipid molecule such as albumin. Glycated albumin is glucose bonded to an alb... Read more
Glycated Albumin Assay Market Insights Glycated albumin is the higher glycated portion of fructosamine. It is measured by a standardized enzymatic methodology, which is easy to perform. Glycated albumin is ... Read more
Helicobacter Pylori Diagnostics Market Insights – Quick Tests Allowing Efficient Diagnosis ... Read more
Neurological Disorder Diagnostics Market– Market Insights Neurological disorder diagnostics tools are medical devices that are used for diagnosing various neurological disorders such as Alzheimer’... Read more
Endocrine Testing Market - Insights Endocrine testing involves measuring of endocrine hormone concentration in order to diagnose the various disorders such as diabetes, hypothyroidism, infertility, and other ... Read more
Global Blood Stream Infection Testing Market Blood stream infection is a condition where any bacterial, fungal or any type of infection is detected in the blood. The condition is evident when the infection enters into the blood stream of... Read more
Metabolic Testing Market- Insights Metabolic testing involves assessment of health and wellbeing of an individual. Metabolic testing equipment are used to screen organ functions and disease conditions such as... Read more
Molecular Diagnostics Market - Global Industry Insights Molecular diagnostics tests are used for detecting disturbance between specific sequences in DNA or RNA, which may be associated with disease. The distu... Read more
Point of Care Diagnostics Market - Insights Point of care diagnosis involves testing of the samples at the point of care to facilitate rapid diagnosis and treatment plan. Point of care diagnosis allows for ea... Read more
Global Enzyme Linked Immunosorbent Assay (ELISA) Market – Creating Substantial Growth in Medical Diagnostics Enzyme Linked Immunosorbent Assay (ELISA) is immunoassay used to identify proteins, peptides,... Read more
POC Platform & Technology Market – Early Detection, Proactive Intervention The point-of-care platforms and technologies have significantly contributed to the transformation of healthcare landscape b... Read more
Cholesterol Testing Services Market - Insights Cholesterol is an organic molecule, which is found in all the cells of body. Cholesterol is the precursor to vitamin D and certain hormones. Increase in choleste... Read more
Liquid Biopsy Market – Insights Liquid biopsy is an advanced cancer diagnostic test that uses bio-fluids such as blood, cerebrospinal fluid (CSF), plasma, and urine for detecting cancer. This non-invasive dia... Read more
Hospital-acquired Disease Testing Market – Market Insights Hospital acquired disease or nosocomial infection is a localized or systemic condition in patients which occurs due to adverse reaction cause... Read more
Hemoglobin A1c test is a common blood test performed for diagnosis and monitoring of type 1 and type 2 diabetes. A1c test results reflect the average blood sugar levels of an individual for the past two to three months. Hemoglobin (Hb) is a protein that links with sug... Read more
Hematology Market – Market Insights Hematology is a branch of medical science concerned with diagnosis, treatment and study of blood and disorders related to blood. It includes the treatment of blood ... Read more
Sales Office (U.S.) : Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154, U.S.
Asia Pacific Intelligence Center (India) : Coherent Market Insights 203, 2nd Floor,
Bremen Business Center, Aundh, Pune,
Maharashtra 411007, India.
UK :
+44-020-8133-4027
JAPAN :
+81-050-5539-1737
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
